Last reviewed · How we verify

NCT06058780

Safety and Efficacy of Implantable Collamer Lens Versus Implantable Phakic Lens IPCL in Myopic Patients; A Comparative Study

Completed NA Last updated 28 September 2023
What this trial tests

NA trial testing Implantable Collamer Lens (ICL) in Myopia in 200 participants. Completed in 1 September 2023.

Timeline
1 August 2021
Primary endpoint
1 August 2023
1 September 2023

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment200
Start date1 August 2021
Primary completion1 August 2023
Estimated completion1 September 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 20 to 25, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Phakic intraocular lenses (pIOL) have proven to be a great alternative to corneal refractive surgery in certain situations. They offer several advantages over corneal techniques, such as being suitable for high myopes and causing relatively fewer higher-order aberrations. In addition, pIOLs have been shown to provide better retinal image magnification and higher contrast sensitivity compared to laser in situ keratomileusis, regardless of whether the myopia is low or high.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Safety and efficacy of implantable phakic contact lens versus implantable collamer lens in myopia correction.
    Amer I, Ziada HA, Elgazzar AF, Abdella WS, et al · · 2023 · cited 2× · PMID 38601054 · DOI 10.51329/mehdiophthal1482

Verify or expand the search:

Other trials of Implantable Collamer Lens (ICL)

Trials testing the same drug.

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06058780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing